April 1, 2025 Katie Brandt, Director of Caregiver Support Services and Public Relations at the MGH FTD Unit, shared her family’s connection to FTD and advice for caregivers on [...]
March 20, 2025 The second episode of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available now. This episode features an interview with [...]
March 5, 2025 AFTD is honored to welcome Katie Brandt, Director of MGH FTD Unit Caregiver Support Services and Public Relations, as the Keynote Speaker for its 2025 Education Conference. A [...]
March 4, 2025 At MGH we reached a milestone on March 4, 2025: one year of being able to administer lecanemab, the first new amyloid-lowering therapy for patients with early-stage Alzheimer’s [...]
February 20, 2025 The first episode of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available now. This episode features an interview [...]
February 11, 2025 Do you have questions about care planning after an FTD diagnosis? The MGH FTD Unit is excited to offer a four part webinar series about the Care Plan Trifecta (CPT), a framework [...]
January 15, 2025 (San Juan, Puerto Rico) Our team members attended the Human Amyloid Imaging meeting that highlights cutting edge research on molecular imaging and other biomarkers of AD, FTD, [...]
December 23, 2024 We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer’s disease (AD) and AD-related neurodegenerative disorders (ADRD) that [...]
October 7, 2024 Dr. Dickerson co-authored a Boston Globe op-ed about cognitive assessment in governmental leaders, writing that “the Federal Aviation Agency requires commercial airline pilots to [...]
September 19, 2024 (Amsterdam, Netherlands) Our team attended the International Society for Frontotemporal Dementias biennial conference, the major worldwide FTD conference, and presented new [...]